Structure-activity studies on [14-(phenylsulfonyl)phenyl] methylpiperazine
led to the discovery of 4-cyclohexyl-alpha-[4-[[4- methoxyphenyl](S)-sulfin
yl]phenyl]-1-piperazineacetonitrile, 1, an M-2 selective muscarinic antagon
ist. Affinity at the cloned human M-2 receptor was 2.7 nM; the M-1/M-2 sele
ctivity is 40-fold. (C) 2000 Elsevier Science Ltd. All rights reserved.